The WHO’s 2026–2036 antimicrobial resistance action plan introduces three transformative expectations for healthcare systems worldwide. First, antibiotic stewardship becomes mandatory rather than aspirational—prescribing only when medically justified, supported by diagnostic confirmation, and aligned with local resistance epidemiology. Second, laboratory surveillance networks will provide real-time resistance data to guide treatment decisions and detect emerging threats early. Third, veterinary antimicrobial regulation and agricultural reform move from peripheral initiatives to central strategic priorities, recognizing that resistant pathogens originate across multiple sectors. These shifts demand institutional commitment: hospitals must establish stewardship programs, diagnostic capacity must expand in resource-limited regions, and regulatory frameworks governing animal medicine require strengthening. Healthcare providers, policymakers, and agricultural stakeholders must understand that individual prescribing decisions now carry collective responsibility for preserving antimicrobial efficacy for future generations.
Was this article helpful?
